ICON (ICLR)
(Delayed Data from NSDQ)
$322.06 USD
+1.48 (0.46%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $321.76 -0.30 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$322.06 USD
+1.48 (0.46%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $321.76 -0.30 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Zacks News
Icon PLC (ICLR) Q3 Earnings Match Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 0.00% and 0.06%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Icon PLC (ICLR) Q3 Earnings Preview: What to Look Out For
by Zacks Equity Research
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OncoCyte (OCX) in Focus: Stock Moves 13.1% Higher
by Zacks Equity Research
OncoCyte (OCX) was a big mover last session, as the company saw its shares rise more than 13% on the day.
Is a Beat in Store for Walgreens Boots (WBA) in Q1 Earnings?
by Zacks Equity Research
Walgreens Boots' (WBA) Retail Pharmacy USA division continues to witness comparable prescription growth as well as a robust retail prescription market.
4 Momentum Stocks to Pick Despite MedTech Policy Debacle
by Zacks Equity Research
Investors might pay heed to Zacks counsel and hitch the momentum ride to tide over the Obamacare debacle.
4 Large-Cap Medical Device Stocks to Buy Amid Political Woes
by Zacks Equity Research
Investors facing political doldrums can safely place their bets on the Medical Device space on four large-cap medical device stocks that are poised for impressive returns over the next five years.
ICON Public Limited (ICLR) Rises: Stock Adds 6.3% in Session
by Zacks Equity Research
ICON Public Limited Company (ICLR) shares rose over 6% in the last trading session.
5 Healthcare Players Poised to Beat Q3 Earnings Estimates
by Sapna Bagaria
The health care sector has some stocks that are likely to deliver positive earnings surprises this earnings season.
What's Your Stock's Price Target?
by Kevin Matras
Kevin Matras explains how to calculate a stock's price target and how to find stocks currently trading below them. Highlighted stocks include ABTL, AHS, EXPR, FIX and ICLR.
What's Your Stock's Price Target?
by Kevin Matras
Kevin Matras explains how to calculate a stock's price target and how to find stocks currently trading below them. Highlighted stocks include AMCX, TTM, FUN, APTS and ICLR.
Market-Caps and Stock Selection for Maximum Gains
by Kevin Matras
Small-cap stocks are often market leaders, but don't overlook the mid-caps and large-caps. See how that leadership has changed over the years and which one is in the lead now.
Reasons to be Bullish this Earnings Season
by Kevin Matras
With earnings season right around the corner, see what the statistics say is in store for this one. Highlighted stocks include ABG, CAKE, ICLR, NCR and PNC.